GENERAL

• Retinal Drug Delivery.
• Blood Retinal Barrier.
• Neuroprotection.
• Regulatory Issues in Drug Delivery to the Eye.

SPECIFIC DELIVERY SYSTEMS

• Intravitreal Injection.
• Anti-angiogenic Agents.
• Intravitreal Antimicrobials.
• Pharmacologic Retinal Reattachment with INS37217 (Denufosol Tetrasodium), a Nucleotide P2Y2 Receptor Agonist.
• Cell Based Delivery Systems.
• Photodynamic Therapy.
• Thermal Sensitive Liposomes.
• Gene Therapy for Retinal Disease.
• Biodegradable Systems.
• Transscleral Drug Delivery to the Retina and Choroid.
• Nondegradable Intraocular Sustained Release Drug Delivery Devices.

LOCAL DRUG DELIVERY APPROACH TO SPECIFIC CLINICAL DISEASES

• Age-Related Macular Degeneration.
• Photodynamic Therapy Human Clinical Studies.
• Age-Related Macular Degeneration Drug Delivery.
• Intraocular Sustained Drug Delivery in Uveitis.
• Drug Delivery for Proliferative Vitreoretinopathy: Prevention and Treatment.
• Pharmacological Treatment in Diabetic Macular Edema.
• Retinal Vein Occlusion.
• Cytomegalovirus (CMV) Retinitis.
• Endophthalmitis.

• Glenn J. Jaffe, Duke University Eye Center, Durham, North Carolina, US
• Paul Ashton, Control Delivery Systems, Watertown, Massachusetts, USA
• P. Andrew Pearson, University of Kentucky, Lexington, USA